001     127669
005     20240228140943.0
024 7 _ |a 10.1016/j.semcancer.2015.07.001
|2 doi
024 7 _ |a pmid:26192966
|2 pmid
024 7 _ |a 1044-579X
|2 ISSN
024 7 _ |a 1096-3650
|2 ISSN
024 7 _ |a altmetric:4299797
|2 altmetric
037 _ _ |a DKFZ-2017-03692
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Utikal, Jochen
|0 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
|b 0
|e First author
|u dkfz
245 _ _ |a Function and significance of MicroRNAs in benign and malignant human stem cells.
260 _ _ |a London
|c 2015
|b Academic Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1524139504_24121
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a MicroRNAs now not only represent a significant mechanism for post-transcriptional gene regulation, but have come to be appreciated as molecules with far reaching tentacles affecting diverse processes and pathologies by modulating amongst others, cellular gene expression, epigentic mechanisms, complex signaling cascades, cell-cell communication, the immune system and microenvironmental interactions between several cell types, tissues and organ systems. In this review, we systematically reflect on the impact of miRNAs on all types of benign and malignant human stem cells, looking at the roles they play in maintaining or changing the stem cell state, and review how aberrations of their expression and function within diverse types of stem cells orchestrate carcinogenesis and metastasis. As a conclusion, we consider it striking to see how similar some miR-driven mechanisms are between different types of stem cells and cancer cells, and how this might support hypotheses of miR-driven embryologic pathway reactivation in metastasis or propose putative functions of miRs in important novel cross-topic fields such as obesity and cancer.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a MicroRNAs
|2 NLM Chemicals
700 1 _ |a Abba, Mohammed
|b 1
700 1 _ |a Novak, Daniel
|0 P:(DE-He78)5f0b1c9863f44d0695555ee3c22b9758
|b 2
|u dkfz
700 1 _ |a Moniuszko, Marcin
|b 3
700 1 _ |a Allgayer, Heike
|0 P:(DE-He78)69067807288b48415ceb4abc43b9ad54
|b 4
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.semcancer.2015.07.001
|g Vol. 35, p. 200 - 211
|0 PERI:(DE-600)1471735-9
|p 200 - 211
|t Seminars in cancer biology
|v 35
|y 2015
|x 1044-579X
909 C O |o oai:inrepo02.dkfz.de:127669
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)5f0b1c9863f44d0695555ee3c22b9758
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)69067807288b48415ceb4abc43b9ad54
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SEMIN CANCER BIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b SEMIN CANCER BIOL : 2015
920 1 _ |0 I:(DE-He78)G300-20160331
|k G300
|l KKE Dermatoonkologie
|x 0
920 1 _ |0 I:(DE-He78)G360-20160331
|k G360
|l KKE Molekulare Onkologie solider Tumoren
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G300-20160331
980 _ _ |a I:(DE-He78)G360-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21